Impact of Denosumab in the Prevention of Bone Loss in Non-menopausal Women With Anorexia Nervosa

NCT02567279 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
2
Enrollment
OTHER
Sponsor class

Stopped Great difficulties were encountered during recruitment, for fear Denozumab. Only 2 patients have been included since the study start.

Conditions

Interventions

Sponsor

University Hospital, Montpellier

Collaborators